AstraZeneca CEO and Key Executive Team

• Pascal Soriot

  Executive Director and Chief Executive Officer
• Johan Hyllner

  Executive Director and Head of Cell Therapy, BioPharmaceuticals R&D
• Hitesh Sanganee

  Head of Emerging Innovations
• Pam Cheng

  Executive Vice-President, Operations, Information Technology and Sustainability
• Ruud Dobber

  Executive Vice-President, BioPharmaceuticals Business Unit
• David Fredrickson

  Executive Vice-President, Oncology Business Unit
• Jeff Pott

  Chief Human Resources Officer, Chief Compliance Officer and General Counsel
• Cristina Duran

  Chief Digital Health Officer, R&D
• Aradhana Sarin

  Executive Director and Chief Financial Officer
• Leon Wang

  Executive Vice-President, International and China President
• Iskra Reic

  Executive Vice-President, Vaccines and Immune Therapies
• Ashling Mulvaney

  VP Sustainability, Access to Healthcare & Healthy Heart Africa
• Sunil Verma

  Senior Vice President, Global Clinical Head, Breast Cancer and Head of Oncology, Medical
• Marc Dunoyer

  Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca
• Susan Galbraith

  Executive Vice-President, Oncology R&D
• Daniel Freeman

  Vice President of Early Development Oncology
• Cristian Massacesi

  Chief Medical Officer and Oncology Chief Development Officer
• Renee Bailey Iacona

  Vice President, Oncology Biometrics, Oncology R&D
• Serban Ghiorghiu

  Vice President, R&D Patient and Clinical Sciences
• Fiona Cookson

  Senior Director, Global Media Relations
• Sinead Keller

  Director, Global Media Relations
• Mark Cobbold

  Vice President, Oncology Early Discovery
• James Weatherall

  Vice President, Data Science and AI, R&D
• Helen Angell

  Senior Director
• Åsa Sjöholm Timén

  Director, Transactions
• Jason Snape

  Global Head of Environmental Protection
• Kiran Nistala

  Vice President, Clinical Immunology
• Joris Silon

  US Country President, BioPharmaceuticals Business Unit
• Elisabeth Björk

  Senior Vice President, Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D
• Clive Green

  Executive Director and Head of Compound Synthesis and Management
• Maria Belvisi

  Senior Vice President, Early Development, Respiratory, Inflammation and Autoimmunity, BioPharmaceuticals R&D
• Maria Groves

  Director
• Tom Keith-Roach

  President, AstraZeneca UK
• Mika Sovak

  Vice President, Global Franchise Head
• Matt Bonam

  Head of BioPharmaceuticals R&D Digital Patient Health and Innovation
• Mark T Esser

  Vice President
• Fredrik Röök

  Senior Director, Transactions
• Menelas Pangalos

  Executive Vice President
• Mohit Manrao

  Senior Vice President, Head of US Oncology
• Matthew Ellis

  Senior Vice President, Early Oncology
• Ruth March

  Senior Vice President of Precision Medicine and Biosamples
• Puja Sapra

  Senior Vice President, Head of Biologics Engineering and Oncology Targeted Delivery
• Euan Ashley

  Non-Executive Director
• Shin Morita

  Vice President, Oncology Business Unit
• Steve Rees

  Vice President Discovery Biology
• Ryan Hicks

  Senior Director, Head of Bioscience Cell Therapy, BioPharmaceuticals R&D Cell Therapy Department
• Slavé Petrovski

  Vice President, Centre for Genomics Research
• Philip Broadley

  Non-Executive Director
• Tonya Villafana

  Vice President, Global Franchise Head, Infection
• Michel Demaré

  Non-Executive Director

Source: astrazeneca.com, astrazeneca.com, astrazeneca.com, astrazeneca.com, openinnovation.astrazeneca.com, astrazeneca.com, astrazeneca.com